We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Touts Positive Phase 3 Data for Anemia-Linked CKD Drug
GSK Touts Positive Phase 3 Data for Anemia-Linked CKD Drug
GlaxoSmithKline’s (GSK) daprodustat increased or maintained hemoglobin levels in patients with anemia due to chronic kidney disease (CKD) across five phase 3 studies, says a new analysis.